Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...
Medical Device Network on MSN10d
Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenueDexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.
A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes | Dexcom ...
Investors with a lot of money to spend have taken a bullish stance on DexCom (NASDAQ ... company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem ...
Dexcom said the warning letter, which the FDA has yet to publish, describes non-conformities in the manufacturing processes and quality management systems at the two facilities. The company does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback